Work

Abstract 6494: The selective YAP/TEAD inhibitor TY-1054 enhances the efficacy of KRAS inhibitors or Trop2-ADC in multiple solid tumors

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-6494

Authors: Shengli Dong, Zhengfei Guo, Zhiyong He, Apeng Liang, Meihua Li, Guangbin Liu, Chao Zhou, Yu Yu, Xinlong Yang, Hongqiang Li, Chengshan Niu, Shaoqing Chen, Jun Li, Yusheng Wu

Institution: TYK Medicines, Inc.

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148759533

Cites:

Cited by:

Related to: